Julio Montaner, MD

Trials

Studies that name Julio Montaner, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:09 UTC. Open this list on ClinicalTrials.gov

• Ph4
  NCT01676363 · Pilot Study of Diflunisal in HIV-infected Adults

  University of British Columbia · terminated · HIV Infection · principal investigator
• Ph4
  NCT00673582 · Effectiveness of Rosuvastatin at Preventing the Progression of Atherosclerosis in HIV Positive Patients

  University of British Columbia · terminated · Atherosclerosis, HIV Infections · study director
• Ph2
  NCT00672191 · Phase II Study of AGS-004 as an Immunotherapeutic in Antiretroviral Therapy (ART)-Treated Subjects Infected With HIV

  Argos Therapeutics · completed · HIV Infections · principal investigator
• Ph4
  NCT00143728 · 3TC or No 3TC for HIV With 3TC Resistance

  University of British Columbia · suspended · HIV Infections · principal investigator
• Ph2/Ph3
  NCT00143702 · D4T or Abacavir Plus Vitamin Enhancement in HIV-Infected Patients (DAVE)

  University of British Columbia · completed · Acidosis, Lactic · principal investigator
• Ph4
  NCT00143689 · NRTI-Sparing Pilot Study

  University of British Columbia · completed · HIV, Mitochondrial Toxicity · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 08:09 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.